Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Bitmine Projects $369 Million in Annual Staking Rewards if All ETH Holdings Are Staked

Bitmine Projects $369 Million in Annual Staking Rewards if All ETH Holdings Are Staked

BitgetBitget2026/10/20 12:13
  • Bitmine projects annual Ethereum staking rewards of $369 million if all its ETH holdings are staked through MAVAN and staking partners.
  • The forecast assumes a 2.58% yield, compared with currently estimated annualized staking revenue of $309 million.
  • As of October 18, 2026, 5,067,309 ETH were staked, representing 84% of its holdings.
  • Total holdings reached 6,041,481 ETH, representing 4.9% of total supply against a 5% ownership target.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bitmine Immersion Technologies Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610200805PR_NEWS_EUPR__FR_FR74964) on October 20, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

智通财经•2026/10/26 04:20
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks

Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.

智通财经•2026/10/26 03:41
Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks